Cite

HARVARD Citation

    Tsuburaya, A. et al. (2016). Molecular Biomarker Study in a Randomised Phase III Trial of Irinotecan Plus S-1 versus S-1 for Advanced Gastric Cancer (GC0301/TOP-002). Clinical oncology. 28 (8), pp. e45-e51. [Online]. 
  
Back to record